COVID‐19 vaccinations : The unknowns, challenges, and hopes
Abstract The entire world has been suffering from the coronavirus disease 2019 (COVID‐19) pandemic since March 11, 2020. More than a year later, the COVID‐19 vaccination brought hope to control this viral pandemic. Here, we review the unknowns of the COVID‐19 vaccination, such as its longevity, asymptomatic spread, long‐term side effects, and its efficacy on immunocompromised patients. In addition, we discuss challenges associated with the COVID‐19 vaccination, such as the global access and distribution of vaccine doses, adherence to hygiene guidelines after vaccination, the emergence of novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variants, and vaccine resistance. Despite all these challenges and the fact that the end of the COVID‐19 pandemic is still unclear, vaccines have brought great hope for the world, with several reports indicating a significant decline in the risk of COVID19‐related infection and hospitalizations..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:94 |
|---|---|
| Enthalten in: |
Journal of Medical Virology - 94(2022), 4, Seite 1336-1349 |
| Beteiligte Personen: |
Mohamed, Kawthar [VerfasserIn] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© 2022 Wiley Periodicals LLC |
|---|
| Umfang: |
14 |
|---|
| doi: |
10.1002/jmv.27487 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY009002766 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY009002766 | ||
| 003 | DE-627 | ||
| 005 | 20230307183105.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230217s2022 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/jmv.27487 |2 doi | |
| 028 | 5 | 2 | |a JMV_JMV27487.xml |
| 035 | |a (DE-627)WLY009002766 | ||
| 035 | |a (WILEY)JMV27487 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.43 |2 bkl | ||
| 100 | 1 | |a Mohamed, Kawthar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID‐19 vaccinations |b The unknowns, challenges, and hopes |
| 264 | 1 | |c 2022 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2022 Wiley Periodicals LLC | ||
| 520 | |a Abstract The entire world has been suffering from the coronavirus disease 2019 (COVID‐19) pandemic since March 11, 2020. More than a year later, the COVID‐19 vaccination brought hope to control this viral pandemic. Here, we review the unknowns of the COVID‐19 vaccination, such as its longevity, asymptomatic spread, long‐term side effects, and its efficacy on immunocompromised patients. In addition, we discuss challenges associated with the COVID‐19 vaccination, such as the global access and distribution of vaccine doses, adherence to hygiene guidelines after vaccination, the emergence of novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variants, and vaccine resistance. Despite all these challenges and the fact that the end of the COVID‐19 pandemic is still unclear, vaccines have brought great hope for the world, with several reports indicating a significant decline in the risk of COVID19‐related infection and hospitalizations. | ||
| 700 | 1 | |a Rzymski, Piotr |4 aut | |
| 700 | 1 | |a Islam, Md Shahidul |4 aut | |
| 700 | 1 | |a Makuku, Rangarirai |4 aut | |
| 700 | 1 | |a Mushtaq, Ayesha |4 aut | |
| 700 | 1 | |a Khan, Amjad |4 aut | |
| 700 | 1 | |a Ivanovska, Mariya |4 aut | |
| 700 | 1 | |a Makka, Sara A. |4 aut | |
| 700 | 1 | |a Hashem, Fareeda |4 aut | |
| 700 | 1 | |a Marquez, Leander |4 aut | |
| 700 | 1 | |a Cseprekal, Orsolya |4 aut | |
| 700 | 1 | |a Filgueiras, Igor Salerno |4 aut | |
| 700 | 1 | |a Fonseca, Dennyson Leandro M. |4 aut | |
| 700 | 1 | |a Mickael, Essouma |4 aut | |
| 700 | 1 | |a Ling, Irene |4 aut | |
| 700 | 1 | |a Arero, Amanuel Godana |4 aut | |
| 700 | 1 | |a Cuschieri, Sarah |4 aut | |
| 700 | 1 | |a Minakova, Kseniia |4 aut | |
| 700 | 1 | |a Rodríguez‐Román, Eduardo |4 aut | |
| 700 | 1 | |a Abarikwu, Sunny O. |4 aut | |
| 700 | 1 | |a Faten, Attig‐Bahar |4 aut | |
| 700 | 1 | |a Grancini, Giulia |4 aut | |
| 700 | 1 | |a Cabral‐Marques, Otavio |4 aut | |
| 700 | 1 | |a Rezaei, Nima |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of Medical Virology |g 94(2022), 4, Seite 1336-1349 |w (DE-627)WLY008980918 |x 10969071 |7 nnns |
| 773 | 1 | 8 | |g volume:94 |g year:2022 |g number:4 |g pages:1336-1349 |g extent:14 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 936 | b | k | |a 44.43 |q ASE |
| 951 | |a AR | ||
| 952 | |d 94 |j 2022 |e 4 |h 1336-1349 |g 14 | ||